pilocarpine has been researched along with quinazolines in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combs, DW; Kirchner, T; Klaubert, DH; Meeks, AS; Rampulla, MS; Rampulla, RA; Ritchie, D; Russell, RK | 1 |
| Funk, CJ | 1 |
| Cavalheiro, EA; da Silva Fernandes, MJ; Doná, F; Ferreira, AT; Vianna, EP | 1 |
| Cao, SX; Chen, XJ; Chen, Z; Duan, S; Li, KX; Li, XM; Lu, YM; Luo, JH; Xu, ZH; Zhang, J; Zhang, JM; Zhu, JM | 1 |
| Bogovyk, R; Fedoriuk, M; Holmes, GL; Isaev, D; Isaeva, E; Krishtal, O; Lunko, O | 1 |
| Al Kury, LT; Bogovyk, R; Fedoriuk, M; Isaeva, E; Krishtal, O; Nikolaienko, O; Savotchenko, A; Semenikhina, M | 1 |
| Benninger, F; Lenz, M; Maggio, N; Neufeld, MY; Shavit-Stein, E; Shimon, MB; Vlachos, A | 1 |
7 other study(ies) available for pilocarpine and quinazolines
| Article | Year |
|---|---|
Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides.
Topics: Animals; Bronchial Spasm; Bronchodilator Agents; Dogs; Drug Design; Female; Guinea Pigs; Hemodynamics; Leukotrienes; Magnetic Resonance Spectroscopy; Male; Ovalbumin; Pilocarpine; Quinazolines; Theophylline | 1990 |
Alkaline phosphatase activity in whitefly salivary glands and saliva.
Topics: Alkaline Phosphatase; Animals; Fluorescent Dyes; Hemiptera; Indoles; Organophosphorus Compounds; Pilocarpine; Quinazolines; Quinazolinones; Saliva; Salivary Glands; Sucrose | 2001 |
Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.
Topics: 5'-Nucleotidase; Adenosine; Animals; Dentate Gyrus; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; In Situ Nick-End Labeling; Male; Neuronal Plasticity; Neuroprotective Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Status Epilepticus; Synapses; Triazoles; Xanthines | 2005 |
Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy.
Topics: Action Potentials; Animals; Biophysics; Caveolin 1; Cell Line, Transformed; Disease Models, Animal; Down-Regulation; Electric Stimulation; Epilepsy; ErbB Receptors; Female; Hippocampus; Humans; Immunoprecipitation; In Vitro Techniques; Kv1.1 Potassium Channel; Male; Mice; Mice, Transgenic; Neuregulin-1; Neurons; Parvalbumins; Patch-Clamp Techniques; Pentylenetetrazole; Peptides; Pilocarpine; Potassium Channel Blockers; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-4; Signal Transduction; Tyrphostins | 2011 |
Effects of protease-activated receptor 1 inhibition on anxiety and fear following status epilepticus.
Topics: Animals; Anxiety; Epilepsy, Temporal Lobe; Fear; Male; Pilocarpine; Pyrroles; Quinazolines; Rats; Rats, Wistar; Receptor, PAR-1; Status Epilepticus | 2017 |
Inhibition of protease-activated receptor 1 ameliorates behavioral deficits and restores hippocampal synaptic plasticity in a rat model of status epilepticus.
Topics: Animals; Behavior, Animal; CA1 Region, Hippocampal; Disease Models, Animal; Epilepsy, Temporal Lobe; Lithium; Long-Term Potentiation; Male; Pilocarpine; Pyrroles; Quinazolines; Rats, Wistar; Receptor, PAR-1; Status Epilepticus | 2019 |
Systemic thrombin inhibition ameliorates seizures in a mouse model of pilocarpine-induced status epilepticus.
Topics: Animals; Anticoagulants; Disease Models, Animal; Hippocampus; Male; Mice; Pilocarpine; Pyrroles; Quinazolines; Receptor, PAR-1; Status Epilepticus; Thrombin | 2019 |